302 related articles for article (PubMed ID: 7629508)
1. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression.
Abdulkadir SA; Krishna S; Thanos D; Maniatis T; Strominger JL; Ono SJ
J Exp Med; 1995 Aug; 182(2):487-500. PubMed ID: 7629508
[TBL] [Abstract][Full Text] [Related]
2. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
[TBL] [Abstract][Full Text] [Related]
3. Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter.
Osborne AR; Zhang H; Fejer G; Palubin KM; Niesen MI; Blanck G
J Biol Chem; 2004 Jul; 279(28):28911-9. PubMed ID: 15105429
[TBL] [Abstract][Full Text] [Related]
4. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
Wright KL; Ting JP
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes.
Panek RB; Moses H; Ting JP; Benveniste EN
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11518-22. PubMed ID: 1454841
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.
Osborne A; Zhang H; Yang WM; Seto E; Blanck G
Mol Cell Biol; 2001 Oct; 21(19):6495-506. PubMed ID: 11533238
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box.
Ono SJ; Song Z
J Biol Chem; 1995 Mar; 270(11):6396-402. PubMed ID: 7890777
[TBL] [Abstract][Full Text] [Related]
8. The function of the octamer-binding site in the DRA promoter.
Voliva CF; Jabrane-Ferrat N; Peterlin BM
Immunogenetics; 1996; 43(1-2):20-6. PubMed ID: 8537118
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of major histocompatibility complex class II gene transcription by nitric oxide and antioxidants.
Grimm M; Spiecker M; De Caterina R; Shin WS; Liao JK
J Biol Chem; 2002 Jul; 277(29):26460-7. PubMed ID: 12006557
[TBL] [Abstract][Full Text] [Related]
10. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of cis-linked regulatory sequences in the HLA DRA promoter by transcription in vitro.
Hume CR; Lee JS
Tissue Antigens; 1990 Sep; 36(3):108-15. PubMed ID: 2278044
[TBL] [Abstract][Full Text] [Related]
12. A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressor.
Song Z; Krishna S; Thanos D; Strominger JL; Ono SJ
J Exp Med; 1994 Nov; 180(5):1763-74. PubMed ID: 7964459
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional regulatory protein, YB-1, promotes single-stranded regions in the DRA promoter.
MacDonald GH; Itoh-Lindstrom Y; Ting JP
J Biol Chem; 1995 Feb; 270(8):3527-33. PubMed ID: 7876087
[TBL] [Abstract][Full Text] [Related]
15. Structural constraints within a trimeric transcriptional regulatory region. Constitutive and interferon-gamma-inducible expression of the HLA-DRA gene.
Vilen BJ; Penta JF; Ting JP
J Biol Chem; 1992 Nov; 267(33):23728-34. PubMed ID: 1331098
[TBL] [Abstract][Full Text] [Related]
16. Role of the X2 box in activated transcription from the DRA promoter in B cells.
Setterblad N; Peterlin BM; Andersson G
Immunogenetics; 1997; 46(4):318-25. PubMed ID: 9218534
[TBL] [Abstract][Full Text] [Related]
17. Distinct regulatory mechanisms for interferon-alpha/beta (IFN-alpha/beta)- and IFN-gamma-mediated induction of Ly-6E gene in B cells.
Khodadoust MM; Khan KD; Park EH; Bothwell AL
Blood; 1998 Oct; 92(7):2399-409. PubMed ID: 9746780
[TBL] [Abstract][Full Text] [Related]
18. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region.
Westerheide SD; Louis-Plence P; Ping D; He XF; Boss JM
J Immunol; 1997 May; 158(10):4812-21. PubMed ID: 9144496
[TBL] [Abstract][Full Text] [Related]
19. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
Hasegawa SL; Boss JM
Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
[TBL] [Abstract][Full Text] [Related]
20. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta.
Panek RB; Benveniste EN
J Immunol; 1995 Mar; 154(6):2846-54. PubMed ID: 7876554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
